open access

Vol 14, No 4 (2019)
Case Reports
Published online: 2019-07-02
Get Citation

Pulmonary hypertension of complex aetiology: contemporary treatment options

Emilia Stepnowska, Alicja Dąbrowska- Kugacka, Grzegorz Raczak, Ewa Lewicka
DOI: 10.5603/FC.a2019.0088
·
Folia Cardiologica 2019;14(4):397-400.

open access

Vol 14, No 4 (2019)
Case Reports
Published online: 2019-07-02

Abstract

We present the case of an 80 year-old female patient with pulmonary arterial hypertension of complex aetiology, including late-diagnosed congenital heart disease. We describe the diagnostic procedures and staged treatment (percutaneous closure of an ostium secundum atrial septal defect and drug treatment with riociguat) which resulted in a significant clinical improvement.

Abstract

We present the case of an 80 year-old female patient with pulmonary arterial hypertension of complex aetiology, including late-diagnosed congenital heart disease. We describe the diagnostic procedures and staged treatment (percutaneous closure of an ostium secundum atrial septal defect and drug treatment with riociguat) which resulted in a significant clinical improvement.
Get Citation

Keywords

pulmonary hypertension, atrial septal defect, chronic thromboembolic pulmonary hypertension, riociguat

About this article
Title

Pulmonary hypertension of complex aetiology: contemporary treatment options

Journal

Folia Cardiologica

Issue

Vol 14, No 4 (2019)

Pages

397-400

Published online

2019-07-02

DOI

10.5603/FC.a2019.0088

Bibliographic record

Folia Cardiologica 2019;14(4):397-400.

Keywords

pulmonary hypertension
atrial septal defect
chronic thromboembolic pulmonary hypertension
riociguat

Authors

Emilia Stepnowska
Alicja Dąbrowska- Kugacka
Grzegorz Raczak
Ewa Lewicka

References (4)
  1. Stepnowska E, Lewicka E, Dąbrowska-Kugacka A, et al. Predictors of poor outcome in patients with pulmonary arterial hypertension: A single center study. PLoS One. 2018; 13(4): e0193245.
  2. Ghofrani HA, Humbert M, Langleben D, et al. Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension. Chest. 2017; 151(2): 468–480.
  3. Ghofrani HA, D'Armini AM, Grimminger F, et al. CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013; 369(4): 319–329.
  4. Galiè N, Grimminger F, Grünig E, et al. PATENT-1 Study Group. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013; 369(4): 330–340.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl